For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.63 in the prior trading day, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.62, down -0.61%. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 10.01 million shares were traded. ALLO stock price reached its highest trading level at $1.64 during the session, while it also had its lowest trading level at $1.53.
Ratios:
Our goal is to gain a better understanding of ALLO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.54 and its Current Ratio is at 8.54. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Chang David D sold 46,668 shares for $1.96 per share. The transaction valued at 91,469 led to the insider holds 5,276,569 shares of the business.
Beneski Benjamin Machinas sold 5,488 shares of ALLO for $10,839 on Mar 14 ’25. The SVP, Chief Technical Officer now owns 218,507 shares after completing the transaction at $1.98 per share. On Mar 14 ’25, another insider, Beneski Benjamin Machinas, who serves as the Officer of the company, bought 5,488 shares for $1.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 351969280 and an Enterprise Value of 150248880. For the stock, the TTM Price-to-Sale (P/S) ratio is 17598.50 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 6829.494 whereas that against EBITDA is -0.616.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.94, which has changed by -0.62237763 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $4.63, while it has fallen to a 52-week low of $1.32. The 50-Day Moving Average of the stock is -14.57%, while the 200-Day Moving Average is calculated to be -31.89%.
Shares Statistics:
The stock has traded on average 5.45M shares per day over the past 3-months and 4070540 shares per day over the last 10 days, according to various share statistics. A total of 212.21M shares are outstanding, with a floating share count of 139.48M. Insiders hold about 35.80% of the company’s shares, while institutions hold 63.64% stake in the company. Shares short for ALLO as of 1740700800 were 39095990 with a Short Ratio of 7.17, compared to 1738281600 on 32048327. Therefore, it implies a Short% of Shares Outstanding of 39095990 and a Short% of Float of 26.22.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
